SSRI discontinuation syndrome: Awareness as an approach to prevention

Postgraduate Medicine

Volumn 114, Issue 2, 2003, Pages 79-84

  Ditto, Kara E ^a  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; METFORMIN; METOPROLOL; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ANTICHOLINERGIC EFFECT; ANXIETY NEUROSIS; ATAXIA; CASE REPORT; DEPRESSION; DIAPHORESIS; DIFFERENTIAL DIAGNOSIS; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; HEADACHE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; LUNG EMBOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; PATIENT COMPLIANCE; PSYCHOSIS; REBOUND; RESTLESSNESS; REVIEW; SEIZURE; SEROTONIN RELEASE; SEXUAL DYSFUNCTION; SKIN TINGLING; STROKE; SYMPTOMATOLOGY; SYNDROME DELINEATION; TACHYCARDIA; VERTIGO; WITHDRAWAL SYNDROME;

EID: 0041519322     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2003.08.1474     Document Type: Review

References (12)

1. Lader M. Benzodiazepine withdrawal states. In: Trimble MR, ed. Benzodiazepines divided. New York: John Wiley & Sons, 1983:17-31
2. Schatzberg AF, Haddad P, Kaplan EM, et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus Panel. J Clin Psychiatry 1997; 58(Suppl 7):5-10
3. Black K, Shea C, Dursun S, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000;25(3):255-61
4. Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry 1997; 58(Suppl 7):17-22
5. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001;76(5):511-27
6. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16(5):356-62
7. Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997;58(Suppl 7):31-6
8. Rosenbaum JF, Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry 1997;58(Suppl 7):37-40
9. Lejoyeux M, Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 1997;58(Suppl 7):11-6
10. Schatzberg AF, Haddad P, Kaplan EM, et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatry 1997;58(Suppl 7):23-7
11. Lazowick AL, Levin GM. Potential withdrawal syndrome associated with SSRI discontinuation. Ann Pharmacother 1995;29(12):1284-5
12. Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram - a review of pharmacological and clinical effects. J Psychiatry Neurosci 2000; 25(3):241-54